Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy
- PMID: 11376385
Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy
Abstract
Objective: Infection is one of the most serious complications of cancer therapy. The rationale of using broad spectrum antibiotics prophylactically has led to a great change in the causative organisms. The aim of the present study is to review retrospectively the type and sequence of infectious complications among Saudi children with acute lymphoblastic leukemia.
Methods: A total of 233 febrile episodes were observed in 137 children with acute lymphoblastic leukemia under induction therapy using modified BFM protocol were studied.
Results: Profound neutropenia (Absolute Neutrophil count < 100/mm3) was encountered in 72 episodes (31%). Clinical signs and symptoms suggestive of infection were evident in 39% of the neutropenic episodes. The respiratory system was the most frequently affected site encountered in 17% of the episodes. Microbiologically documented infection was recorded in 59% (n=137) of the fever and granulocytopenia episodes. In 96 episodes (41%), there was neither clinical nor microbiological evidence of infection fever of unknown origin. Out of the 932 cultures, positive isolates were detected in 346 cultures (37%). Gram positive cocci were the most frequently organisms (54%) followed by gram negative bacilli (39%). In the current study, 7 patients (3%) died because of direct or indirect consequences of infection.
Conclusion: The current study stresses the importance of frequent reviewing of the type, frequency, severity and outcome of infection complications over years to detect changing epidemiological patterns.
Similar articles
-
Infections in childhood acute lymphoblastic leukemia: an analysis of 222 febrile neutropenic episodes.Pediatr Hematol Oncol. 2008 Jun;25(5):385-92. doi: 10.1080/08880010802106564. Pediatr Hematol Oncol. 2008. PMID: 18569840
-
Risk factors for infection-related outcomes during induction therapy for childhood acute lymphoblastic leukemia.Pediatr Infect Dis J. 2009 Dec;28(12):1064-8. doi: 10.1097/INF.0b013e3181aa6eae. Pediatr Infect Dis J. 2009. PMID: 19773675
-
Mucocutaneous findings in febrile neutropenic children with acute leukemias.J Med Assoc Thai. 2005 Jun;88(6):817-23. J Med Assoc Thai. 2005. PMID: 16083222
-
Neutropenic fever syndromes in patients undergoing cytotoxic therapy for acute leukemia and myelodysplastic syndromes.Semin Hematol. 2009 Jul;46(3):259-68. doi: 10.1053/j.seminhematol.2009.03.002. Semin Hematol. 2009. PMID: 19549578 Review.
-
Management of infections in children with cancer.Hematol Oncol Clin North Am. 1987 Dec;1(4):801-39. Hematol Oncol Clin North Am. 1987. PMID: 3323184 Review.
Cited by
-
Varicella-Zoster Virus Infections in Pediatric Malignancy Patients: A Seven-Year Analysis.Turk J Haematol. 2016 Dec 1;33(4):346-348. doi: 10.4274/tjh.2016.0046. Epub 2016 Oct 18. Turk J Haematol. 2016. PMID: 27751970 Free PMC article.
-
Pulmonary Infectious Complications in Children with Hematologic Malignancies and Chemotherapy-Induced Neutropenia.Diseases. 2020 Aug 19;8(3):32. doi: 10.3390/diseases8030032. Diseases. 2020. PMID: 32824956 Free PMC article. Review.
-
Bacterial Spectrum, Isolation Sites and Susceptibility Patterns of Pathogens in Adult Febrile Neutropenic Cancer Patients at a Specialist Hospital in Saudi Arabia.World J Oncol. 2014 Dec;5(5-6):196-203. doi: 10.14740/wjon850w. Epub 2014 Dec 3. World J Oncol. 2014. PMID: 29147403 Free PMC article.
-
Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy.Infect Drug Resist. 2014 Nov 6;7:289-99. doi: 10.2147/IDR.S70486. eCollection 2014. Infect Drug Resist. 2014. PMID: 25395866 Free PMC article.
-
Infections in a pediatric patient cohort with acute lymphoblastic leukemia during the entire course of treatment.Support Care Cancer. 2006 Mar;14(3):277-84. doi: 10.1007/s00520-005-0884-6. Epub 2005 Nov 4. Support Care Cancer. 2006. PMID: 16270193
MeSH terms
Substances
LinkOut - more resources
Medical